Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
ZEO ScientifiX
AddedFeb 19, 2024
UpdatedJul 4, 2026
ZEO ScientifiX

ZEO ScientifiX

Public

Organicell, a Miami-based biotech firm, pioneers in developing exosome therapeutics and placental tissue research since 2014.

HQ
Miami, FL, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

Founded in 2014 and headquartered in Miami, Florida, Organicell Regenerative Medicine is a biotech company specializing in exosome therapeutics and placental tissue research. The company's core mission is to revolutionize regenerative medicine by integrating exosome technology with other synergistic therapies, aiming to become a leading healthcare technology incubator for biologic medicine. Organicell's flagship product, Patient Pure X™ (PPX™), is a concentrated autologous exosome product derived from a patient's own blood, designed to reduce inflammation and promote tissue healing.

Notable figures associated with Organicell include its team of pioneering scientists and medical professionals dedicated to advancing exosome research. The company has attracted significant investment from stakeholders interested in the future of regenerative medicine. Key achievements include the development and successful deployment of PPX™, which has shown promising results in decreasing inflammation and aiding tissue repair. Overall, Organicell has made a substantial impact on the biotech industry by pushing the boundaries of biologic medicine and offering innovative therapeutic solutions.

ZEO ScientifiX - Similar Companies

Celularity logo

Celularity

celularity.com

Xostem logo

Xostem

Exovita Biosciences logo

Exovita Biosciences

Exogenesis logo

Exogenesis

Rion logo

Rion

rionsr.com

Entelexo Biotherapeutics logo

Entelexo Biotherapeutics

entelexo.com

U.S. Stem Cell logo

U.S. Stem Cell

us-stemcell.com

AgeX Therapeutics logo

AgeX Therapeutics

NeXtGen Biologics logo

NeXtGen Biologics

42Bio logo

42Bio

42bio.com

RegeneRx Biopharmaceuticals logo

RegeneRx Biopharmaceuticals

Mantra Bio logo

Mantra Bio

mantrabio.com

Tissue Genesis logo

Tissue Genesis

tissuegenesis.com

Platelet BioGenesis logo

Platelet BioGenesis

Direct Biologics logo

Direct Biologics

ZEO ScientifiX - Quick Facts

Who are ZEO ScientifiX's competitors?

Companies similar to ZEO ScientifiX include Celularity, Xostem, Exovita Biosciences and Exogenesis.

When was ZEO ScientifiX founded?

ZEO ScientifiX was founded in 2014.

Where is ZEO ScientifiX's headquarters located?

ZEO ScientifiX's headquarters is located in Miami, FL, US.

When was ZEO ScientifiX's last funding round?

ZEO ScientifiX's most recent funding round was for $4M (USD) in July 2022.

How much has ZEO ScientifiX raised to-date?

As of Jul 20, 2022, ZEO ScientifiX has raised a total of $4.5M (USD).

How many employees does ZEO ScientifiX have?

ZEO ScientifiX has 22 employees as of Feb 6, 2024.

ZEO ScientifiX - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Consumers
  • Enterprise
Main Product
  • Exosome Therapeutics
Tags
  • Healthtech
Unique IDs
  • secCik: 0001557376
  • ticker: ZEOX
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2836Biological Products, Except Diagnostic Substances
  • 2800Chemicals And Allied Products
  • 2830Drugs
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 18 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325414Biological Product (except Diagnostic) Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 3790Miscellaneous Transportation Equipment
  • 3700Transportation Equipment
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research